1. Home
  2. YMAB vs EPSM Comparison

YMAB vs EPSM Comparison

Compare YMAB & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • EPSM
  • Stock Information
  • Founded
  • YMAB 2015
  • EPSM 2010
  • Country
  • YMAB United States
  • EPSM China
  • Employees
  • YMAB N/A
  • EPSM N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • EPSM
  • Sector
  • YMAB Health Care
  • EPSM
  • Exchange
  • YMAB Nasdaq
  • EPSM Nasdaq
  • Market Cap
  • YMAB 386.7M
  • EPSM 333.5M
  • IPO Year
  • YMAB 2018
  • EPSM 2025
  • Fundamental
  • Price
  • YMAB $8.61
  • EPSM $38.30
  • Analyst Decision
  • YMAB Buy
  • EPSM
  • Analyst Count
  • YMAB 10
  • EPSM 0
  • Target Price
  • YMAB $13.91
  • EPSM N/A
  • AVG Volume (30 Days)
  • YMAB 874.6K
  • EPSM 375.7K
  • Earning Date
  • YMAB 11-07-2025
  • EPSM 01-01-0001
  • Dividend Yield
  • YMAB N/A
  • EPSM N/A
  • EPS Growth
  • YMAB N/A
  • EPSM N/A
  • EPS
  • YMAB N/A
  • EPSM 0.02
  • Revenue
  • YMAB $85,385,000.00
  • EPSM $12,518,070.00
  • Revenue This Year
  • YMAB N/A
  • EPSM N/A
  • Revenue Next Year
  • YMAB $13.97
  • EPSM N/A
  • P/E Ratio
  • YMAB N/A
  • EPSM $1,906.26
  • Revenue Growth
  • YMAB N/A
  • EPSM N/A
  • 52 Week Low
  • YMAB $3.55
  • EPSM $4.23
  • 52 Week High
  • YMAB $16.11
  • EPSM $155.00
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.21
  • EPSM N/A
  • Support Level
  • YMAB $8.50
  • EPSM N/A
  • Resistance Level
  • YMAB $8.56
  • EPSM N/A
  • Average True Range (ATR)
  • YMAB 0.02
  • EPSM 0.00
  • MACD
  • YMAB -0.12
  • EPSM 0.00
  • Stochastic Oscillator
  • YMAB 100.00
  • EPSM 0.00

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About EPSM Epsium Enterprise Limited Ordinary Shares

Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.

Share on Social Networks: